Filing Details

Accession Number:
0001237648-21-000044
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-19 15:42:53
Reporting Period:
2021-08-18
Accepted Time:
2021-08-19 15:42:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1038133 Heska Corp HSKA In Vitro & In Vivo Diagnostic Substances (2835) 770192527
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1392223 Nancy Wisnewski 3760 Rocky Mountain Avenue
Loveland CO 80538
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-08-18 6 $270.71 55,499 No 4 S Direct
Common Stock Disposition 2021-08-18 19 $270.71 55,480 No 4 S Direct
Common Stock Disposition 2021-08-18 2 $270.58 55,478 No 4 S Direct
Common Stock Disposition 2021-08-18 25 $270.55 55,453 No 4 S Direct
Common Stock Disposition 2021-08-18 7 $270.51 55,446 No 4 S Direct
Common Stock Disposition 2021-08-18 12 $270.51 55,434 No 4 S Direct
Common Stock Disposition 2021-08-18 274 $270.50 55,160 No 4 S Direct
Common Stock Disposition 2021-08-18 102 $270.41 55,058 No 4 S Direct
Common Stock Disposition 2021-08-18 198 $270.28 54,860 No 4 S Direct
Common Stock Disposition 2021-08-18 200 $270.20 54,660 No 4 S Direct
Common Stock Disposition 2021-08-18 100 $270.15 54,560 No 4 S Direct
Common Stock Disposition 2021-08-18 55 $270.00 54,505 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct